Factors regulating insulin-like growth factor-binding protein-3 binding, processing, and potentiation of insulin-like growth factor action

Endocrinology

Volumn 137, Issue 6, 1996, Pages 2286-2292

  Conover, Cheryl A ^a   Clarkson, Jay T ^a   Bale, Laurie K ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 3;

ANIMAL CELL; ARTICLE; CELL ADHESION; CROSS LINKING; DRUG POTENTIATION; DRUG RECEPTOR BINDING; ENDOCYTOSIS; FIBROBLAST; HORMONAL REGULATION; HORMONE ACTION; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROCESSING; RECEPTOR AFFINITY;

EID: 0029889690     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.137.6.8641177     Document Type: Article

References (40)

1. Shimasaki S, Ling N 1991 Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5, and -6). Prog Growth Factor Res 3:243-266
2. Jones JI, Clemmons DR 1995 Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16:3-34
3. Zapf J 1995 Physiological role of the insulin-like growth factor binding proteins. Eur J Endocrinol 132:645-654
4. DeMellow JSM, Baxter RC 1988 Growth hormone-dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-I-stimulated DNA synthesis in human skin fibroblasts. Biochem Biophys Res Commun 156:199-204
5. Gopinath R, Walton PE, Etherton TD 1989 An acid-stable insulin-like growth factor (IGF)-binding protein from pig serum inhibits binding of IGF-I and IGF-II to vascular endothelial cells. J Endocrinol 120:231-236
6. Blum WF, Jenne EW, Reppin JF, Kietzmann It Ranke MB, Bierich JR 1989 Insulin-like growth factor I (IGF-I)-binding protein complex is a better mitogen than free IGF-I. Endocrinology 125:766-772
7. Conover CA, Ronk M, Lombana F, Powell DR 1990 Structural and biological characterization of bovine insulin-like growth factor binding protein-3. Endocrinology 127:2795-2803
8. Ernst M, Rodan GA 1990 Increased activity of insulin-like growth factor (IGF) in osteoblastic cells in the presence of growth hormone (GH): positive correlation with the presence of the GH-induced IGF-binding protein BP-3. Endocrinology 127:807-814
9. Bicsak TA, Shimonaka M, Malkowski M, Ling N 1990 Insulin-like growth factor-binding protein (IGFBP) inhibition of granulosa cell function: effect on cyclic adenosine 3′,3′-monophosphate, deoxyribonucleic acid synthesis, and comparison with the effect of an IGF-I antibody. Endocrinology 127:2184-2189
10. Conover CA, Powell DR 1991 Insulin-like growth factor (IGF)-binding protein-3 blocks IGF-I-induced receptor down-regulation and cell desensitization in cultured bovine fibroblasts. Endocrinology 129:710-716
11. Conover CA 1991 Glycosylation of insulin-like growth factor binding protein-3 (IGFBP-3) is not required for potentiation of IGF-I action: evidence for processing of cell-bound IGFBP-3. Endocrinology 129:3259-3268
12. Conover CA 1992 Potentiation of insulin-like growth factor (IGF) action by IGF-binding protein-3: studies of underlying mechanism. Endocrinology 130:3191-3199
13. Pratt SE, Pollak MN 1993 Insulin-like growth factor binding protein 3 (ICF-BP3) inhibits estrogen-stimulated breast cancer cell proliferation. Biochem Biophys Res Commun 198:292-297
14. Cohen P, Lamson G, Okajima T, Rosenfeld RG 1993 Transfection of the human insulin-like growth factor binding protein-3 gene into BALB/c fibroblasts inhibits cellular growth. Mol Endocrinol 7:380-386
15. Chen J-C, Shao Z-M, Sheikh MS, Hussain A, LeRoith D, Roberts CT Jr, Fontana JA 1994 Insulin-like growth factor-binding protein enhancement of insulin-like growth factor-I (IGF-I)-mediated DNA synthesis and IGF-I binding in a human breast carcinoma cell line. J Cell Physiol 158:69-78
16. Ramagnolo D, Akers RM, Byatt JC, Wong EA, Turner JD 1994 IGF-I-induced IGFBP-3 potentiates the mitogenic actions of IGF-I in mammary epithelial MD-IGF-I cells. Mol Cell Endocrinol 102:131-139
17. Rappaport MS, Smith EP 1995 Insulin-like growth factor (IGF) binding protein 3 in the rat testis: follicle-stimulating hormone dependence of mRNA expression and inhibition of IGF-I action on cultured sertoli cells. Biol Reprod 52:419-425
18. Koutsilieris M, Frenette G, Akoum A, Lemay A, Lazure C 1995 N-terminal truncated forms of insulin-like growth factor binding protein-3 in the peritoneal fluid of women without laparoscopic evidence of endometriosis. Fertil Steril 63:314-321
19. Marcelli M, Haidacher SJ, Plymate SR, Birnbaum RS 1995 Altered growth and insulin-like growth factor-binding protein-3 production in PC3 prostate carcinoma cells stably transfected with a constitutively active androgen receptor complementary deoxyribonucleic acid. Endocrinology 136:1040-1048
20. McCusker RH, Camacho-Hubner C, Bayne ML, Cascieri MA, Clemmons DR 1990 Insulin-like growth factor (IGF) binding to human fibroblast and glioblastoma cells: the modulating effect of cell released IGF binding proteins (IGFBPs). J Cell Physiol 144:244-253
21. Francis GL, Ross M, Ballard FJ, Milner SJ, Senn C, McNeil KA, Wallace JC, King R, Wells JRE 1992 Novel recombinant fusion protein analogues of insulin-like growth factor (IGF)-I indicate the relative importance of IGF-binding protein and receptor binding for enhanced biological potency. J Mol Endocrinol 8:213-223
22. + extrusion processes. Am J Physiol 268:C210-C217
23. +-ATPases are functionally expressed in plasma membranes of human tumor cells. Am J Physiol 265:C1015-C1029
24. 24a. Conovor CA, Clarkson JT, Durham SK, Bale LK 1994 Cellular actions of insulin-like growth factor binding protein-3. In: LeRoith D, Raizada MK (eds) Current Directions in Insulin-Like Growth Factor Research. Plenum Press, New York, pp 255-266
25. Conover CA, Clarkson JT, Bale LK 1994 Physiological concentrations of insulin induce cellular desensitization to the mitogenic effects of insulin-like growth factor I. Diabetes 43:1130-1137
26. Lamson G, Giudice LC, Cohen P, Liu F, Gargosky S, Muller HL, Oh Y, Wilson KF, Hintz RL, Rosenfeld RG 1993 Proteolysis of IGFBP-3 may be a common regulatory mechanism of IGF action in vivo. Growth Regul 3:91-95
27. Blat C, Villaudy J, Binoux M 1994 In vivo proteolysis of serum insulin-like growth factor (IGF) binding protein-3 results in increased availability of IGF to target cells. J Clin Invest 93:2286-2290
28. Delbe J, Blat C, Desauty G, Harel L 1991 Presence of IDF45 (mIGFBP-3) binding sites on chick embryo fibroblasts. Biochem Biophys Res Commun 179:495-501
29. Smith EP, Lu L, Chernausek SD, Klein DJ 1994 Insulin-like growth factor-binding protein-3 (IGFBP-3) concentration in rat Sertoli cell-conditioned medium is regulated by a pathway involving association of IGFBP-3 with cell surface proteoglycans. Endocrinology 135:359-364
30. Berg T, Gjoen T, Bakke O 1995 Physiological functions of endosomal proteolysis. Biochem J 307:313-326
31. Haass C, Hung AY, Schlossmacher MG, Teplow DB, Selkoe DJ 1993 β-Amyloid peptide and a 3-kDa fragment are derived by distinct cellular mechanisms. J Biol Chem 268:3021-3024
32. +-ATPase inhibitor bafilomycin A1 differentially affects proteolytic processing of mutant and wild-type b-amyloid precursor protein. J Biol Chem 270:6186-6192
33. Booth BA, Boes M, Andress DL, Dake BL, Kiefer MC, Maack C, Linhardt RJ, Bar K, Caldwell EEO, Weiler J, Bar RS 1995 IGFBP-3 and IGFBP-5 association with endothelial cells: role of C-terminal heparin binding domain. Growth Regul 5:1-17
34. Hodgkinson SC, Napier JR, Spencer GSG, Bass JJ 1994 Glycosaminoglycan binding characteristics of the insulin-like growth factor-binding proteins. J Mol Endocrinol 13:105-112
35. Martin JL, Ballesteros M, Baxter RC 1992 Insulin-like growth factor-I (IGF-I) and transforming growth factor-β1 release IGF-binding protein-3 from human fibroblasts by different mechanisms. Endocrinology 131:1703-1710
36. Yang YW-H, Yanagishita M, Rechler MM, Heparin-inhibitable binding of insulin-like growth factor binding protein-3 (IGFBP-3) to rat glial cells and human fibroblasts is not to heparin sulfate glycosaminoglycans. 77th Annual Meeting of The Endocrine Society, Washington DC, 1995, p 164
37. Oh Y, Muller HL, Lamson G, Rosenfeld RG 1993 Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells; cell surface binding and growth inhibiton. J Biol Chem 268:14964-14971
38. Hodgkinson S, Fowke P, Somai NA, McQuoid M 1995 Proteins in tissue extracts which bind insulin-like growth factor binding protein-3 (IGFBP-3). J Endocrinol 145:R1-R6
39. Yayon A, Klagsbrun M, Esko JD, Leder P, Ornitz DM 1991 Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 64:841-848
40. Damsky CH, Werb Z 1992 Signal transduction by integrin receptors for extracellular matrix: cooperative processing of extracellular information. Curr Opin Cell Biol 4:772-781